drugset / Trial / NCT00029614

Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

NCT00029614

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivity Disorder (ADHD).

Timeline

Start
2006-05
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified